Abstract | BACKGROUND:
Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival of melanoma cells. In this context, the SLUG gene has recently been characterized as a major regulator of melanocytes and melanoma cell survival. METHODS: RESULTS: It was found that SLUG siRNA increased cisplatin-induced cell death and rendered the drug active in vitro at half its plasmatic peak concentration. Such activity was correlated with an upregulation of the pro-apoptotic gene, PUMA. Furthermore, SLUG siRNA increased the capacity of fotemustine to elicit cell death and induced p21WAF1 upregulation, resulting in cell cycle arrest. Interestingly, this pathway did not require functional p53. CONCLUSION: These findings suggest that SLUG siRNA enhances the efficacy of two of the most widely used drugs to treat melanoma.
|
Authors | Ivan Vannini, Massimiliano Bonafe, Anna Tesei, Marco Rosetti, Francesco Fabbri, Gianluca Storci, Paola Ulivi, Giovanni Brigliadori, Dino Amadori, Wainer Zoli |
Journal | Cellular oncology : the official journal of the International Society for Cellular Oncology
(Cell Oncol)
Vol. 29
Issue 4
Pg. 279-87
( 2007)
ISSN: 1570-5870 [Print] Netherlands |
PMID | 17641412
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Nitrosourea Compounds
- Organophosphorus Compounds
- RNA, Small Interfering
- SNAI1 protein, human
- Snail Family Transcription Factors
- Transcription Factors
- Tumor Suppressor Protein p53
- fotemustine
- Cisplatin
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Cell Cycle
(drug effects)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Cisplatin
(pharmacology)
- DNA Mutational Analysis
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Melanoma
(genetics, pathology)
- Nitrosourea Compounds
(pharmacology)
- Organophosphorus Compounds
(pharmacology)
- RNA, Small Interfering
(genetics, metabolism)
- Snail Family Transcription Factors
- Transcription Factors
(antagonists & inhibitors, genetics, metabolism)
- Tumor Suppressor Protein p53
(metabolism)
|